Epigral Reports Q4FY25 PAT Growth of 13% to Rs 870 Million

07 May 2025 CW Team

Reflecting its strong performance, the company’s balance sheet strengthened further in FY25. Return on capital employed (ROCE) rose to 25% from 18% in FY24, and Net Debt/EBITDA improved significantly to 0.7x from 2.0x. Credit rating was upgraded to CRISIL AA from CRISIL AA-.

Chairman and Managing Director Maulik Patel stated, “We closed FY2025 with the highest-ever revenue of Rs 25.65 billion, a 33% growth over the previous year. This was driven by an 11% volume increase, especially in high-value products. Our Derivatives & Specialty segment grew 24% and now contributes 54% to total revenue, up from 45% in FY24.”

The company plans to expand its CPVC and Epichlorohydrin (ECH) capacities, which are expected to come online in H1FY27 and contribute thereafter. The integrated complex is expected to further benefit once these projects reach full capacity.

Dividend Update:

Epigral’s board proposed a final dividend of Rs 3.5 per equity share, bringing the total dividend for FY2025 to Rs 6.0 per share (60% of the face value of Rs 10).

Strategic & financial highlights for FY2025:

Credit rating upgraded to CRISIL AA.
Capital expenditure stood at Rs 1.95 billion in FY2025.
Successfully raised Rs 3.33 billion via QIP to support growth.
CPVC Resin capacity expanded to 75,000 TPA; approved to double to 150,000 TPA.
Epichlorohydrin capacity to double to 100,000 TPA.
Commissioned CPVC Compound and Chlorotoluenes Value Chain facilities.

Q4FY25 operational & financial highlights:

Revenue grew 20% YoY to Rs 6.31 billion.
Derivatives & Specialty segment’s revenue contribution rose to 52% from 48% in Q4FY24.
EBITDA increased 12% to Rs 1.73 billion, with a margin of 28%.
PAT rose 13% to Rs 870 million.
Captive chlorine usage increased to 76%.

FY2025 operational & financial summary:

Sales volume grew 11%, with overall capacity utilisation at 81% (vs 78% in FY24).
Highest-ever revenue at Rs 25.65 billion, up 33% YoY.
Derivatives & Specialty business contributed 54% to revenue.
EBITDA rose 48% to Rs 7.11 billion (vs Rs 4.81 billion in FY24).
EBITDA margin improved to 28% from 25%.
PAT surged 82% to Rs 3.57 billion.

(BSE)

Image Source: Image Generated by ChatGPT

Your next big infra connection is waiting at RAHSTA 2025 – Asia’s Biggest Roads & Highways Expo, Jio World Convention Centre, Mumbai. Don’t miss out!

Epigral Limited, a leading integrated chemical manufacturer in India, announced its financial results for the quarter ended March 31, 2025. The company reported a 13% year-on-year rise in profit after tax (PAT) at Rs 870 million in Q4FY25, compared to Rs 770 million in Q4FY24. Revenue for the quarter stood at Rs 6.31 billion, up 20% from Rs 5.26 billion in the same quarter last year.Reflecting its strong performance, the company’s balance sheet strengthened further in FY25. Return on capital employed (ROCE) rose to 25% from 18% in FY24, and Net Debt/EBITDA improved significantly to 0.7x from 2.0x. Credit rating was upgraded to CRISIL AA from CRISIL AA-.Chairman and Managing Director Maulik Patel stated, “We closed FY2025 with the highest-ever revenue of Rs 25.65 billion, a 33% growth over the previous year. This was driven by an 11% volume increase, especially in high-value products. Our Derivatives & Specialty segment grew 24% and now contributes 54% to total revenue, up from 45% in FY24.”The company plans to expand its CPVC and Epichlorohydrin (ECH) capacities, which are expected to come online in H1FY27 and contribute thereafter. The integrated complex is expected to further benefit once these projects reach full capacity.Dividend Update:Epigral’s board proposed a final dividend of Rs 3.5 per equity share, bringing the total dividend for FY2025 to Rs 6.0 per share (60% of the face value of Rs 10).Strategic & financial highlights for FY2025:Credit rating upgraded to CRISIL AA.Capital expenditure stood at Rs 1.95 billion in FY2025.Successfully raised Rs 3.33 billion via QIP to support growth.CPVC Resin capacity expanded to 75,000 TPA; approved to double to 150,000 TPA.Epichlorohydrin capacity to double to 100,000 TPA.Commissioned CPVC Compound and Chlorotoluenes Value Chain facilities.Q4FY25 operational & financial highlights:Revenue grew 20% YoY to Rs 6.31 billion.Derivatives & Specialty segment’s revenue contribution rose to 52% from 48% in Q4FY24.EBITDA increased 12% to Rs 1.73 billion, with a margin of 28%.PAT rose 13% to Rs 870 million.Captive chlorine usage increased to 76%.FY2025 operational & financial summary:Sales volume grew 11%, with overall capacity utilisation at 81% (vs 78% in FY24).Highest-ever revenue at Rs 25.65 billion, up 33% YoY.Derivatives & Specialty business contributed 54% to revenue.EBITDA rose 48% to Rs 7.11 billion (vs Rs 4.81 billion in FY24).EBITDA margin improved to 28% from 25%.PAT surged 82% to Rs 3.57 billion.(BSE)Image Source: Image Generated by ChatGPT

Infrastructure Transport

01 Sep 2025

Indian Railways Marks New Milestone with 4.5 km Long ‘Rudrastra’ Trial

Indian Railways has successfully conducted the trial run of Asia’s longest freight train, named ‘Rudrastra’, achieving a new milestone in cargo transportation, as per news reports. The 4.5 km-long train began its trial from Ganjkhwaja railway station in Chandauli, Uttar Pradesh, and travelled to Garhwa in Jharkhand. Covering a distance of 209 km in 5 hours and 10 minutes, it maintained an average speed of 40.5 km per hour. The train was formed by combining three long-haul racks, with ..

Infrastructure Energy

01 Sep 2025

UltraTech Launches India’s First On-Site Hybrid RTC Renewable Energy Project

UltraTech Cement has operationalised a 7.5 MW round-the-clock (RTC) hybrid renewable energy project at its Sewagram Cement Works in Gujarat. The first-of-its-kind solution combines bifacial solar modules with trackers, wind energy and battery storage, co-located on-site, to ensure uninterrupted power for cement manufacturing without grid reliance. The project was executed in collaboration with clean energy solutions provider Gentari. Installed as a behind-the-meter system, it is the country..

Infrastructure Transport

09 Sep 2025

Patna Metro Trials Successful, Red Line Priority Corridor to Launch This Month

Patna is set to roll out its first metro rail service later this month, with successful trial runs conducted on the Red Line priority corridor, the Patna Metro Rail Corporation announced.On 7 September, a metro train completed a test run between the Patna depot and Bhootnath station. Officials said the trials involved rigorous checks of rolling stock fitness, overhead electrification (OHE), and track alignment and stability to ensure operational safety and performance.The corridor from the New Pataliputra Bus Terminal to Bhoothnath has been designated as the priority stretch and will be the fi..